Nasus Pharma Ltd (NSRX) PT Lowered to $18 at Citizens: NS002 Likely Best-in-Class
Tweet Send to a Friend
Citizens analyst Jason Butler lowered the price target on Nasus Pharma Ltd (NYSE: NSRX) to $18.00 (from $19.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
